Lorcaserin Treatment for Extended-Release Naltrexone Induction and Retention for Opioid Use Disorder Individuals: A Pilot, Randomized Trial

BACKGROUND: Opioid Use Disorder (OUD) is a significant public health problem associated with severe morbidity and mortality. While effective pharmacotherapies are available, limitations exist with each. Induction onto extended-release naltrexone (XR-NTX) is more difficult than initiation of buprenor...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Drug Alcohol Depend
Hlavní autoři: Levin, Frances R., Mariani, John J., Pavlicova, Martina, Choi, C. Jean, Basaraba, Cale, Mahony, Amy L., Brooks, Daniel J., Naqvi, Nasir, Bisaga, Adam
Médium: Artigo
Jazyk:Inglês
Vydáno: 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7856237/
https://ncbi.nlm.nih.gov/pubmed/33418204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2020.108482
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky